Showing results (121-130 of 130) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The Journal of Craniofacial Surgery|May 30, 2013
A novel approach to frontal sinus surgery: treatment algorithm revisitedPeter Niclas Broer, Steven M Levine, Neil Tanna, et al.The Journal of Family Practice|February 14, 2013
How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men?Mary Elizabeth Sexton, Joseph J Baker, Keisuke Nakagawa, et al.Journal of Reconstructive Microsurgery|January 2, 2013
Ten-year evolution utilizing computer-assisted reconstruction for giant ameloblastomaP Niclas Broer, Neil Tanna, Peter B Franco, et al.Plos One|July 14, 2012
Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic backgroundKelsey J Weigel, Laura Rues, Edward J Doyle, et al.NPJ Digital Medicine|November 28, 2024
A virtual scalable model of the Hepatic Lobule for acetaminophen hepatotoxicity predictionStelian Camara Dit Pinto, Jalal Cherkaoui, Debarshi Ghosh, et al.Cells|January 14, 2015
High Reproducibility of ELISPOT Counts from Nine Different LaboratoriesSrividya Sundararaman, Alexey Y Karulin, Tameem Ansari, et al.Antimicrobial Agents and Chemotherapy|May 13, 2009
Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolatesJie Fang, Michael J Wichroski, Steven M Levine, et al.Plos Pathogens|January 14, 2012
Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to Bacillus anthracisJill K Terra, Bryan France, Christopher K Cote, et al.Antimicrobial Agents and Chemotherapy|December 21, 2006
Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions presentDaniel J Tenney, Ronald E Rose, Carl J Baldick, et al.Plos One|February 15, 2018
Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infectionScott Balsitis, Volodymyr Gali, Pamela J Mason, et al.Pageof 13